Latest filings (excl ownership)
8-K
Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
15 Apr 24
DEFA14A
Additional proxy soliciting materials
4 Apr 24
DEF 14A
Definitive proxy
4 Apr 24
8-K
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant Review
27 Mar 24
10-K
2023 FY
Annual report
5 Mar 24
8-K
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
5 Mar 24
8-K
Marinus Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2023 ZTALMY® Net Product Revenue and Provides Business Update
4 Jan 24
8-K
Other Events
28 Nov 23
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
7 Nov 23
8-K
Other Events
28 Sep 23
8-K
Marinus Pharmaceuticals Highlights Advancing Pipeline and Commercial Strategy at Investor and Analyst Event
19 Sep 23
8-K
Other Events
21 Aug 23
8-K
Other Events
15 Aug 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
10 Aug 23
8-K
ZTALMY is the first treatment approved by the European Commission for seizures associated with CDKL5 deficiency disorder in children and adolescents
1 Aug 23
S-8
Registration of securities for employees
28 Jun 23
8-K
The European Commission decision is expected within 67 days of the CHMP opinion
30 May 23
8-K
Submission of Matters to a Vote of Security Holders
30 May 23
8-K
Departure of Directors or Certain Officers
17 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
11 May 23
8-K
Marinus Pharmaceuticals Appoints Marvin H. Johnson, Jr. to its Board of Directors
18 Apr 23
EFFECT
Notice of effectiveness
12 Apr 23
DEFA14A
Additional proxy soliciting materials
11 Apr 23
DEF 14A
Definitive proxy
11 Apr 23
CORRESP
Correspondence with SEC
11 Apr 23
UPLOAD
Letter from SEC
5 Apr 23
8-K
Entry into a Material Definitive Agreement
31 Mar 23
S-3
Shelf registration
31 Mar 23
8-K
Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone in the Treatment of Lennox-Gastaut Syndrome
22 Mar 23
8-K
Other Events
10 Mar 23
10-K
2022 FY
Annual report
9 Mar 23
8-K
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
7 Mar 23
8-K
Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors
30 Jan 23
8-K
Marinus Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2022 ZTALMY® Net Product Revenue and Provides Business Update
5 Jan 23
8-K
Other Events
6 Dec 22
8-K
Other Events
5 Dec 22
8-K
Departure of Directors or Certain Officers
17 Nov 22
Latest ownership filings
SC 13G
CITADEL ADVISORS LLC
25 Apr 24
SC 13G
TANG CAPITAL PARTNERS LP
19 Apr 24
4
Scott Braunstein
27 Mar 24
4
Christina Shafer
22 Feb 24
4
MARTHA E MANNING
22 Feb 24
4
Joseph Hulihan
21 Feb 24
4
Steven Pfanstiel
21 Feb 24
4
Scott Braunstein
21 Feb 24
SC 13G/A
Lion Point Capital, LP
14 Feb 24
SC 13G/A
Cormorant Asset Management, LP
14 Feb 24
SC 13G/A
EVENTIDE ASSET MANAGEMENT, LLC
14 Feb 24
SC 13G
PRUDENTIAL FINANCIAL INC
14 Feb 24
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 24
SC 13G/A
Avoro Capital Advisors LLC
14 Feb 24
SC 13G/A
SUVRETTA CAPITAL MANAGEMENT, LLC
13 Feb 24
SC 13G
JENNISON ASSOCIATES LLC
8 Feb 24
SC 13G/A
ADAGE CAPITAL PARTNERS GP, L.L.C.
7 Feb 24
SC 13G
FRANKLIN RESOURCES INC
6 Feb 24
SC 13G
BlackRock Inc.
25 Jan 24
4
Sarah B. Noonberg
19 Jan 24
4
Marvin Johnson
19 Jan 24
4
Christine Berni Silverstein
19 Jan 24
4
Elan Ezickson
19 Jan 24
4
Seth H. Z. Fischer
19 Jan 24
4
Sara Nochur
19 Jan 24
4
Charles Austin
19 Jan 24
4
TIMOTHY M MAYLEBEN
19 Jan 24
4
Christina Shafer
19 Jan 24
4
MARTHA E MANNING
19 Jan 24
4
Joseph Hulihan
19 Jan 24
4
Steven Pfanstiel
19 Jan 24
4
Scott Braunstein
19 Jan 24
SC 13G
Cormorant Asset Management, LP
10 Oct 23
4
Christina Shafer
8 Aug 23
4
Scott Braunstein
8 Aug 23
4
Steven Pfanstiel
8 Aug 23
4
MARTHA E MANNING
8 Aug 23
4
Joseph Hulihan
8 Aug 23
SC 13G
ADAGE CAPITAL PARTNERS GP, L.L.C.
6 Jul 23
4
Sarah B. Noonberg
17 May 23